HANDOK Inc. (KRX:002390)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,640
-50 (-0.47%)
Mar 13, 2026, 3:30 PM KST
Market Cap138.87B -10.9%
Revenue (ttm)535.14B +0.7%
Net Income-2.15B
EPS-162.00
Shares Out12.99M
PE Ration/a
Forward PEn/a
Dividend200.00 (1.87%)
Ex-Dividend DateFeb 26, 2026
Volume7,586
Average Volume31,804
Open10,600
Previous Close10,690
Day's Range10,500 - 10,690
52-Week Range9,990 - 14,250
Beta0.39
RSI44.51
Earnings DateMar 19, 2026

About HANDOK

HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food supplements under the NatureSet brand; food and beverages; and medical nutrition products. In addition, the company engages in real estate leasing. The co... [Read more]

Sector Healthcare
Founded 1954
Employees 940
Stock Exchange Korea Stock Exchange
Ticker Symbol 002390
Full Company Profile

Financial Performance

In 2024, HANDOK's revenue was 507.36 billion, a decrease of -2.94% compared to the previous year's 522.74 billion. Losses were -52.56 billion, 82.5% more than in 2023.

Financial Statements